Weekly Oral HIV Treatment Looks Good at Two Years
|
A once-weekly oral regimen combining the HIV capsid
inhibitor lenacapavir and the experimental nucleoside reverse transcriptase
translocation ... |
AbbVie's HIV Study: A Potential Game Changer in HIV Treatment
... Antiretroviral Therapy Undergoing Analytical Treatment Interruption. The study aims to assess changes in disease activity, adverse events, and ... View article...